Hematopoetic stem cell transplantation for solid tumors in Europe
ANNALS OF ONCOLOGY, vol.15, no.4, pp.653-660, 2004 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 15 Issue: 4
- Publication Date: 2004
- Doi Number: 10.1093/annonc/mdh142
- Journal Name: ANNALS OF ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.653-660
- Keywords: donor type, Europe, hematopoetic stem cell transplants, solid tumors, transplant rates, HIGH-DOSE CHEMOTHERAPY, BONE-MARROW-TRANSPLANTATION, RISK BREAST-CANCER, RANDOMIZED-TRIAL, RESCUE, THERAPY, EBMT
- Ankara University Affiliated: Yes
Abstract
Background: Hematopoetic stem cell transplants (HSCT) are discussed as treatment options for patients with solid tumors. Transplant numbers have changed substantially over the last decade, few controlled studies are available and different opinions prevail. Objective information on current practice is needed.